Download PDF
CC BY-NC-ND 4.0 · South Asian J Cancer 2016; 05(04): 211-212
DOI: 10.4103/2278-330X.195348
Letters to the Editor

Pigmented villonodular synovitis of proximal tibiofibular joint: Rare site of involvement treated with medical management

Ashish Gulia
Department of Surgical Orthopedic Oncology, Tata Memorial Hospital, Mumbai, Maharashtra
,
Sunita Dhanda
Department of Radiology, Tata Memorial Hospital, Mumbai, Maharashtra
,
Ajay Puri
Department of Surgical Orthopedic Oncology, Tata Memorial Hospital, Mumbai, Maharashtra
,
Mukta Ramadwar
Department of Pathology, Tata Memorial Hospital, Mumbai, Maharashtra
› Author Affiliations Financial support and sponsorship: Nil.
› Further Information
  PDF Download Permissions and Reprints


Publication History

Article published online:
28 December 2020

© 2016. MedIntel Services Pvt Ltd. This is an open access article published by Thieme under the terms of the Creative Commons Attribution-NonDerivative-NonCommercial-License, permitting copying and reproduction so long as the original work is given appropriate credit. Contents may not be used for commercial purposes, or adapted, remixed, transformed or built upon. (https://creativecommons.org/licenses/by-nc-nd/4.0/.)

Thieme Medical and Scientific Publishers Pvt. Ltd.
A-12, 2nd Floor, Sector 2, Noida-201301 UP, India

 

  • References

  • 1 Murphey MD, Rhee JH, Lewis RB, Fanburg-Smith JC, Flemming DJ, Walker EA. Pigmented villonodular synovitis: Radiologic-pathologic correlation. Radiographics 2008;28:1493-518.
  • 2 Garner HW, Ortiguera CJ, Nakhleh RE. Pigmented villonodular synovitis. Radiographics 2008;28:1519-23.
  • 3 Sheldon PJ, Forrester DM, Learch TJ. Imaging of intraarticular masses. Radiographics 2005;25:105-19.
  • 4 Hughes TH, Sartoris DJ, Schweitzer ME, Resnick DL. Pigmented villonodular synovitis: MRI characteristics. Skeletal Radiol 1995;24:7-12.
  • 5 Ryan RS, Louis L, O′Connell JX, Munk PL. Pigmented villonodular synovitis of the proximal tibiofibular joint. Australas Radiol 2004;48:520-2.
  • 6 Kwon JH, Han JH, Almeida VR, Kim SH, Park HJ, Nha KW. Localized pigmented villonodular synovitis of the proximal tibiofibular joint. Knee Surg Relat Res 2014;26:249-52.
  • 7 Lui TH. Arthroscopic treatment of pigmented villonodular synovitis of the proximal tibiofibular joint. Knee Surg Sports Traumatol Arthrosc 2015;23:2278-82.
  • 8 Llauger J, Palmer J, Rosón N, Cremades R, Bagué S. Pigmented villonodular synovitis and giant cell tumors of the tendon sheath: Radiologic and pathologic features. AJR Am J Roentgenol 1999;172:1087-91.
  • 9 Huang GS, Lee CH, Chan WP, Chen CY, Yu JS, Resnick D. Localized nodular synovitis of the knee: MR imaging appearance and clinical correlates in 21 patients. AJR Am J Roentgenol 2003;181:539-43.
  • 10 Tyler WK, Vidal AF, Williams RJ, Healey JH. Pigmented villonodular synovitis. J Am Acad Orthop Surg 2006;14:376-85.
  • 11 Dines JS, DeBerardino TM, Wells JL, Dodson CC, Shindle M, DiCarlo EF, et al. Long-term follow-up of surgically treated localized pigmented villonodular synovitis of the knee. Arthroscopy 2007;23:930-7.
  • 12 Cupp JS, Miller MA, Montgomery KD, Nielsen TO, O′Connell JX, Huntsman D, et al. Translocation and expression of CSF1 in pigmented villonodular synovitis, tenosynovial giant cell tumor, rheumatoid arthritis and other reactive synovitides. Am J Surg Pathol 2007;31:970-6.
  • 13 van der Heijden L, Gibbons CL, Dijkstra PD, Kroep JR, van Rijswijk CS, Nout RA, et al. The management of diffuse-type giant cell tumour (pigmented villonodular synovitis) and giant cell tumour of tendon sheath (nodular tenosynovitis). J Bone Joint Surg Br 2012;94:882-8.
  • 14 West RB, Rubin BP, Miller MA, Subramanian S, Kaygusuz G, Montgomery K, et al. A landscape effect in tenosynovial giant-cell tumor from activation of CSF1 expression by a translocation in a minority of tumor cells. Proc Natl Acad Sci U S A 2006;103:690-5.
  • 15 Stacchiotti S, Crippa F, Messina A, Pilotti S, Gronchi A, Blay JY, et al. Response to imatinib in villonodular pigmented synovitis (PVNS) resistant to nilotinib. Clin Sarcoma Res 2013;3:8.